Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees6,870
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable
Bruker (NASDAQ:BRKR) Frequently Asked Questions
What is Bruker's stock symbol?
Bruker trades on the NASDAQ under the ticker symbol "BRKR."
How often does Bruker pay dividends? What is the dividend yield for Bruker?
Bruker declared a quarterly dividend on Thursday, November 14th. Investors of record on Monday, December 2nd will be paid a dividend of $0.04 per share on Friday, December 20th. This represents a $0.16 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Friday, November 29th. View Bruker's Dividend History.
How were Bruker's earnings last quarter?
Bruker Co. (NASDAQ:BRKR) released its earnings results on Thursday, October, 31st. The medical research company reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.05. The medical research company earned $521.10 million during the quarter, compared to analyst estimates of $493.52 million. The company's revenue was up 11.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.37 EPS. View Bruker's Earnings History.
When is Bruker's next earnings date?
What price target have analysts set for BRKR?
13 Wall Street analysts have issued 12 month price targets for Bruker's shares. Their forecasts range from $39.00 to $60.00. On average, they expect Bruker's stock price to reach $50.58 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for Bruker.
What is the consensus analysts' recommendation for Bruker?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.
Has Bruker been receiving favorable news coverage?
News coverage about BRKR stock has trended neutral on Sunday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Bruker earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Bruker.
Are investors shorting Bruker?
Bruker saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 2,630,000 shares, an increase of 9.6% from the January 15th total of 2,400,000 shares. Based on an average daily trading volume, of 526,000 shares, the days-to-cover ratio is currently 5.0 days. Currently, 2.6% of the company's shares are short sold. View Bruker's Current Options Chain.
Who are some of Bruker's key competitors?
Some companies that are related to Bruker include Agilent Technologies (A), Cambrex (CBM), aTyr Pharma (LIFE), BG Medicine (BGMD), Bio-Rad Laboratories (BIO), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Fluidigm (FLDM), Harvard Bioscience (HBIO), Illumina (ILMN), Luminex (LMNX), Mettler-Toledo International (MTD), Pacific Biosciences of California (PACB), PerkinElmer (PKI) and Thermo Fisher Scientific (TMO).
What other stocks do shareholders of Bruker own?
Who are Bruker's key executives?
Bruker's management team includes the folowing people:
- Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
- Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
- Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
- Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
- Dr. Falko Busse, Exec. Officer (Age 52)
Who are Bruker's major shareholders?
Bruker's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (10.78%), Acadian Asset Management LLC (1.88%), State Street Corp (0.95%), AJO LP (0.92%), Bank of America Corp DE (0.79%) and TD Asset Management Inc. (0.55%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.
Which major investors are selling Bruker stock?
BRKR stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Acadian Asset Management LLC, AQR Capital Management LLC, First Trust Advisors LP, Los Angeles Capital Management & Equity Research Inc., Thrivent Financial for Lutherans, MERIAN GLOBAL INVESTORS UK Ltd and MERIAN GLOBAL INVESTORS UK Ltd. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.
Which major investors are buying Bruker stock?
BRKR stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Goldman Sachs Group Inc., Mackay Shields LLC, TD Asset Management Inc., Mckinley Capital Management LLC Delaware, Chase Investment Counsel Corp, Knights of Columbus Asset Advisors LLC and UBS Group AG. View Insider Buying and Selling for Bruker.
How do I buy shares of Bruker?
Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Bruker's stock price today?
One share of BRKR stock can currently be purchased for approximately $50.51.
MarketBeat Community Rating for Bruker (NASDAQ BRKR)
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
